US FDA completes inspection at Cadila's Ahmedabad facility
Cadila Healthcare stated that United States Food and Drug Administration (FDA) has completed inspection at its manufacturing facility in Ahmedabad with no observations.
"US FDA inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, located at SEZ, Ahmedabad from January 27, 2020 to February 4, 2020," the company said in a BSE filing.
The site manufactures oncology injectables for the regulated markets.
Cadila Healthcare Ltd is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. It is a manufacturer of generic drugs.